An interventional study of Ventral Hernia Repair in Ventral Hernia, sponsored by Lucas Beffa. Recruiting at 5 sites in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-14.
Sponsored by Lucas Beffa · Not applicable, Interventional, and Treatment
This is a randomized trial comparing open retromuscular ventral hernia repair to robotic retromuscular ventral hernia repair.
This is a randomized trial comparing open retromuscular ventral hernia repair to robotic retromuscular ventral hernia repair. This is a superiority trial with a primary outcome of length of stay in the hospital, theorizing that robotic retromuscular ventral hernia repairs are superior to open ventral hernia repairs by reducing length of stay by 24 hours. Patients will be blinded to the intervention, groups will be in parallel, and the primary outcome (when the patient is discharged) will be determined by a blinded assessor.
230 studies on the registry are indexed under Hernia, Ventral; 45 are open to participants now.
This study's planned enrollment of 200 is above the median of 90 across 153 interventional studies indexed under Hernia, Ventral.
Browse Hernia, Ventral studies →This is the only study on the registry with Lucas Beffa as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
These patients will undergo open retromuscular ventral hernia repairs
Procedure: Ventral Hernia Repair
These patients will undergo robotic retromuscular ventral hernia repairs.
Procedure: Ventral Hernia Repair
Patients will undergo retromuscular ventral hernia repair
Length of Stay
Time in the hospital after the surgery
Time frame: 30 days
Post-operative wound complications
any abnormal wound healing
Time frame: 30 day and one year
Other post operative complications
Heart attacks, acute kidney injury, admissions to ICU, respiratory failure
Time frame: 30 days
Readmission rate
Readmission to the hospital within 30 days of the surgery
Time frame: 30 days
Opioid consumption
Opioid prescribed and consumed
Time frame: 30 days and one year
Acute pain scores
Numeric Rating Scale-11 pain scores daily, 0-10 with 0 being no pain and 10 being the worst pain for first five days after surgery
Time frame: 5 days after surgery
Hernia Related Specific Quality of Life Score
Score of 0-100 with lower scores indicating worse quality of life
Time frame: 30 days and one year
Direct cost
Cost to the hospital
Time frame: 30 days
Hernia recurrence
Hernia recurrence
Time frame: 30 days and one year
Quality of life scores using European Hernia Society (EuraHS) scale
EuraHS is a hernia specific quality of life scale with three domains: pain, restrictions of activity, and cosmesis. 0-30 with higher scores indicating a worse quality of life.
Time frame: 30 day and one year
Plan to share: No
Started Jul 2022 (actual). Primary completion is estimated for Aug 2027, 60 months after the start.
Of 75 non-industry interventional studies with no phase under Hernia, Ventral, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 48. This study's planned 60 months is above that.
Counting every sponsor, half of 88 studies reached it within 37 months; a quarter within 19 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.